VISN 5 MIRECC - General Publications 2007
About Us • Clinical • Education • Research
VISN 5 MIRECC home
Batten, S. V., & Santanello, A. P. (2007). Review of Mindfulness and Acceptance: Expanding the Cognitive-Behavioral Tradition. Clinical Psychology Review, 27, 406-407.
Bellack, A. S., Bennett, M. E., & Gearon, J. S. (2007). Behavioral Treatment for Substance Abuse in People with Serious and Persistent Mental Illness: A Handbook for Mental Health Professionals. New York: Taylor and Francis.
Bellack, A. S., Green, M. F., Cook, J. A., et al., (2007). Assessment of community functioning in people with schizophrenia and other severe mental illnesses: A white paper based on an NIMH-sponsored workshop. Schizophrenia Bulletin, 33, 805-822.
Bennett, M.E. & Gjonbalaj, S. (2007). The Problem of Dual Diagnosis. In M. Hersen, S. Turner, & D. Beidel (Eds), Adult Psychopathology and Diagnosis (Fifth Ed). New York: John Wiley and Sons.
Buchanan, R. W., Conley, R. R., Dickinson, D., Ball, M. P., Feldman, S., Gold, J. M., & McMahon, R. P. (2007). Galantamine for the treatment of cognitive impairments in patients with schizophrenia. American Journal of Psychiatry. November 6. [Epub ahead of print]
Carpenter, W. T. (2007). Cognitive impairment and negative symptoms in schizophrenia treatment. In G. Thaker & W. T. Carpenter (Eds.), The Year in Schizophrenia (Vol 1, pp. 233-267). Oxford: Clinical Publishing.
Carpenter, W. T. (2007). Deconstructing and reconstructing illness syndromes associated with psychosis. World Psychiatry, 6(2), 28-29.
Carpenter, W. T. (2007). Schizophrenia: disease, syndrome or dimensions? Family Process, 46, 199-206.
Carpenter, W. T. & Thaker, G. K. (2007). Evidence-based therapeutics – introducing the Cochrane Corner. Schizophrenia Bulletin, 33(3), 633-634.
Daumit, G., Durant, N., Dixon, L. (2007). Co-occurring substance use and somatic disorders. In G. Thaker & W. Carpenter (Eds.), The Year in Schizophrenia. Ashland: Clinical Publishing.
Deutsch, S. I., Mastropaolo, J., Schwartz, B. L., Rosse, R. B., & Gaskins, B. (2007). NMDA receptor hypofunction in schizophrenia: from mouse to man. In G. McAlpine (Ed.), Focus on Signal Transduction Research (pp. 103-122). New York: Nova Science Publishers, Inc.
Deutsch, S. I., Rosse, R. B., Schwartz, B. L., Schooler, N. R., Gaskins, B. L., Long, K. D., & Mastropaolo, J. (2007). Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: Development of a selective α7 nicotinic acetylcholine receptor agonist strategy. European Neuropsychopharmacology. July 24. [Epub ahead of print]
Dickinson, D., Bellack, A. S., & Gold, J. M. (2007). Social/communication skills, cognition, and vocational functioning in schizophrenia. Schizophrenia Bulletin, 33(5), 1213-20.
Dickinson, D., & Gold, J. M. (2007). Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia. Schizophrenia Bulletin. Aug 16. [Epub ahead of print]
Dickinson, D., & Gold, J. M. (2007). Processing speed and the digit symbol substitution test in schizophrenia. In J. Deluca & J. Kalmar (Eds.), Information Processing Speed in Clinical Populations. New York: Taylor & Francis Group.
Dickinson, D., Ramsey, M., & Gold, J. M. (2007). Overlooking the obvious: A meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry, 64, 532-542.
DiClemente, C. C., Nidecker, M., & Bellack, A. S. (2007). Motivation and the stages of change among individuals with co-occurring disorders. Journal of Substance Abuse Treatment. June 14. [Epub ahead of print].
Dixon, L., Adler, D., Berlant, J., Dulit, R., Goldman, B., Hackman, A., Oslin, D., Siris, S., Sonis, W., & Valenstein, M. (2007). Psychiatrists and primary caring: what are our boundaries of responsibility? Psychiatric Services, 58(5), 600-602.
Dixon, L., Medoff, D., Wohlheiter, K., DiClemente, C., Goldberg, R., Kreyenbuhl, J., Adams, C., Mfalila, C., Lucksted, A., & Davin, C. (2007). Correlates of severity of smoking among persons with SMI. American Journal on Addictions, 16 (2), 101-110.
Drapalski, A. L., Murray-Swank, A., Lucksted, A., Goldberg, R., Boyd Ritscher, J., Forbes, C., & Dixon, L.B. (2007). Internalized stigma and discrimination among consumers with SMI (abstract). Schizophrenia Bulletin, 33(2), 587.
Genderson, M. R., Dickinson, D., Diaz-Asper, C. M., Egan, M. F., Weinberger, D. R., & Goldberg, T. E. (2007). Factor analysis of neurocognitive tests in a large sample of schizophrenia probands, their siblings, and healthy controls. Schizophrenia Research, 94, 231-239.
Goldberg, R., Dickerson, F., Kreyenbuhl, J., Medoff, D., Wohlheiter, K., Fang, L., & Dixon, L. (2007). Quality of Diabetes Care for Persons with Severe Mental Illness. Psychiatric Services, 58, 536-543.
Goldberg, R., & Gmyrek, A. (2007). Use of medical emergency departments by veterans with schizophrenia. Psychiatric Services, 58(4), 566-567.
Goldberg, R., Kreyenbuhl, J., Medoff, D., Dickerson, F., Wohlheiter, K., Fang, L., & Dixon, L. (2007). Quality of diabetes care among adults with serious mental illness. Psychiatric Services, 58(4), 536-543.
Hackman, A., Brown, C., Yang, Y., Goldberg, R., Kreyenbuhl, J., Lucksted, A., Wohlheiter, K., & Dixon, L. (2007). Consumer satisfaction with inpatient psychiatric treatment among persons with severe mental illness. Community Mental Health Journal, 43(6), 551-564.
Hackman, A., & Dixon, L. (2007). Assertive community treatment. In P. M. Gillig & H. L. McQuistion (Eds.), Clinical Guide to the Treatment of the Homeless Mentally Ill Person (pp 51-64). Arlington, VA: American Psychiatric Publishing, Inc.
Harvey, P. D., Velligan, D. I., & Bellack, A. S. (2007). Performance-based measures of functional skills: Usefulness in clinical treatment studies. Schizophrenia Bulletin, 33(5), 1138-1148.
Himelhoch, S., McCarthy, J., Ganoczy, D., Medoff, D., Dixon, L., & Blow, F. (2007). Understanding Associations between Serious Mental Illness and HIV among Veterans: A National Multivariate Analysis. Psychiatric Services, 58, 1165-1172.
Himelhoch, S., Medoff, D., & Oyeniyi, G. (2007). Efficacy of group psychotherapy to reduce depressive symptoms among HIV infected individuals: a systematic review and meta-analysis. AIDS Patient Care and STDs, 21(10), 732-739.
Himelhoch, S., Powe, N., Breaky, W., et al. (2007). Schizophrenia, AIDS and the decision to prescribe HAART: results of a national survey of HIV clinicians. In M. B. Blank & M. M. Eisenberg (Eds.), HIV Issues with Mental Health and Illness. New York: Haworth Press.
Hong, L. E., Summerfelt, A., Adami, H. M., Wonodi, I., Buchanan, R. W., & Thaker, G. K. (2007). Independent domains of inhibitory gating in schizophrenia and the effect of stimulus interval. American Journal of Psychiatry, 164, 61-65.
Kelly, D. L., Kreyenbuhl, J., Buchanan, R. W., & Malhotra, A. K. (2007). Why Not Clozapine? Clinical Schizophrenia & Related Psychoses, 1(1), 92-95.
Kelly D. L., Kreyenbuhl, J., Dixon, L., Love, R. C., Medoff, D., & Conley, R. R. (2007). Clozapine underutilization and discontinuation in African-Americans due to leucopenia. Schizophrenia Bulletin, 33(5), 1221-1224.
Kinnaman, J. S., Bellack, A. S., Brown, C. H., & Yang, Y. (2007). Assessment of motivation to change in dually-diagnosed schizophrenia patients. Addictive Behaviors, 32(9), 1798-1813.
Kinnaman, J. S., Slade, E., Bennett, M. E., & Bellack, A. S. (2007). Examination of contingency payments to dually-diagnosed patients in a multi-faceted behavioral treatment. Addictive Behaviors, 32, 1480-1485.
Kreyenbuhl ,J., Marcus, S. C., West, J. C., Wilk, J., & Olfson, M. (2007). Adding or switching antipsychotic medications in treatment-refractory schizophrenia. Psychiatric Services, 58(7), 983-990.
Kreyenbuhl, J., Valenstein, M., McCarthy, J. F., Ganoczy, D., & Blow, F. C. (2007). Antipsychotic polypharmacy in the VA Health System: Patient characteristics and treatment patterns. Psychiatric Services, 58(4), 489-495.
Long, K. D., Mastropaolo, J., Rosse, R. B., & Deutsch, S. I. (2007). Exogenously administered D-serine failed to potentiate the ability of MK-801 to antagonize electrically precipitated seizures in nonhandled control and stressed mice. European Neuropsychopharmacology, 17(1), 53-57.
Murray-Swank, A. B., Dixon, L. B., & Stewart, B. (2007). Practical Interview Strategies for Building an Alliance with the Families of Patients with Severe Mental Illness. Psychiatric Clinics of North America, 30, 167-180.
Murray-Swank, A., Glynn, S., Cohen, A. N., Sherman, M., Medoff, D. P., Fang, L. J., et al. (2007). Family contact, experience of family relationships, and views about family involvement in treatment among VA consumers with serious mental illness. Journal of rehabilitation research and development, 44(6), 801-812.
Murray-Swank, A. B., Goldberg, R. W., Dickerson, F. B., Medoff, D. P., Wohlheiter, K. A., & Dixon, L. B. (2007). Correlates of religious service attendance and contact with religious leaders among persons with co-occurring Serious Mental Illness and Type 2 Diabetes. Journal of Nervous and Mental Disease,195(5), 382-388.
Peer, J., Kupper, Z., Long, J. D., Brekke, J. S., & Spaulding, W. (2007). Identifying mechanisms of treatment effects and recovery in rehabilitation of schizophrenia: Longitudinal analytic methods. Clinical Psychology Review, 27, 296-714.
Peer, J., & Spaulding, W. (2007). Heterogeneity in recovery of psychosocial functioning during psychiatric rehabilitation: An exploratory study using latent growth mixture modeling. Schizophrenia Research, 93, 186-193.
Prentice, K. J., Appelbaum, P. S., Conley, R. R., & Carpenter, W. T., Jr. (2007). Maintaining informed consent validity during lengthy research protocols. IRB: Ethics and Human Research, 29(6), 1-6.
Prentice, K. J., Gold, J. M. & Buchanan, R. W. (2007). The Wisconsin Card Sorting impairment in schizophrenia is evident in the first four trials. Schizophrenia Research. Oct 12 [Epub ahead of print].
Prentice, K. J., Robinson, B. M. & Gold, J. M. (2007). Error processing in schizophrenia: the role of WM load. Abstracts of the 11th International Congress on Schizophrenia Research. Schizophrenia Bulletin, 33, 203-631.
Schooler, N. R. (2007). Efficacy and safety of conventional and atypical antipsychotics in first-episode schizophrenia: a review of the literature. Clinical Schizophrenia & Related Psychoses, 1, 27-38.
Tenhula, W. N., Strong Kinnaman, J. E., & Bellack, A. S. (2007). Is learning potential associated with social skills in schizophrenia? Journal of Rehabilitation Research and Developm ent, 44(6), 827-836.
Thaker, G. K. (2007). Endophenotypic studies in schizophrenia: promise and challenges. Schizophrenia Bulletin, 33, 1-2.
Thaker, G. K., & Carpenter, W. T. (Eds.). (2007). The Year in Schizophrenia, Volume 1. Oxford: Clinical Publishing.
Woody, I., Reeves, R., Carmichael, D., Verovsky, I., Avila, M. T., Elliott, A., Hong, L. E., Adami, H. M., & Thaker, G. K. (2007). Tardive dyskinesia in children treated with atypical antipsychotic medications. Movement Disorders, 22(12), 1777-1782.
NOTE: Names in bold are VISN 5 MIRECC Investigators
